EUVIMEDEUVIMED entdecken
Crossref

Safety Concerns Put a Stop to Maternal RSV Vaccine Study

Emily Harris

JAMA · 2024

DOI: 10.1001/jama.2024.5155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Early Termination of Clinical Trials, Premature Birth, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Termination of Clinical TrialsPremature BirthRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesFemaleHumansInfant, NewbornPregnancyPatient SafetyPregnancy Complications, InfectiousUnited States

Substanzen

Respiratory Syncytial Virus Vaccines

Zitieren

APA

Harris, E. (2024). Safety Concerns Put a Stop to Maternal RSV Vaccine Study. JAMA. https://doi.org/10.1001/jama.2024.5155

Vancouver

Harris E. Safety Concerns Put a Stop to Maternal RSV Vaccine Study. JAMA. 2024. doi:10.1001/jama.2024.5155

BibTeX
@article{Harris2024,
  author = {Harris, Emily},
  title = {Safety Concerns Put a Stop to Maternal RSV Vaccine Study},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.5155}
}
Kostenlos starten →